Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CTMX
#2165
CytomX Therapeutics, Inc.
5.3
7
-0.37%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.37%
Monthly Change
-9.60%
6 month change
+156.94%
Cambio anual
+701.49%
Cierres anteriores
5.3
9
Open
5.3
7
Bid
Ask
Low
5.3
7
High
5.3
7
Volumen
86
Markets
Acciones
Atención Sanitaria
CTMX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
64.78 M
65.39 M
66.23 M
67.72 M
80.1 M
—
Valuation ratios
Enterprise value
232.48 M
77.62 M
-87.02 M
97.28 M
44.45 M
879.73 M
Price to earnings ratio
—
—
-1.07
-169
2.71
16.06
Price to sales ratio
—
—
1.99
1.23
0.63
5.07
Price to cash flow ratio
—
—
0.96
2.23
1.01
8.98
Price to book ratio
—
—
-1.23
-2.63
-191.42
-189.04
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.25
0.38
0
0.26
0.38
Return on equity %
0.66
0.94
1.16
0.01
69.89
13.81
Return on invested capital %
253.68
322.4
333.03
-2.95
82.29
306.88
Gross margin %
100
100
100
100
100
400
Operating margin %
48.43
120.42
190.61
6.41
18.1
317.78
EBITDA margin %
—
—
—
—
—
—
Net margin %
32.77
120.17
186.82
0.56
23.08
300.9
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.21
2.92
1.55
1.17
1.25
10.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.29
0.2
0.18
0.44
0.86
0.93
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.69
0.76
1.02
0.69
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
1.45
2.38
1.2
4.21
Net current asset value per share
—
—
3.61
2.48
1.27
4.44
Tangible book value per share
—
—
1.28
0.62
-0.01
1.82
Working capital per share
—
—
1.29
0.37
0.25
2.3
Book value per share
—
—
1.3
0.64
0.01
1.87
Noticias
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
CytomX en Cumbre Guggenheim: Prometedor tratamiento para cáncer colorrectal
CytomX en la Cumbre de Guggenheim: Prometedor camino para tratamiento de CRC
CytomX at Guggenheim Summit: Promising CRC Treatment Path
Qiagen (QGEN) Meets Q4 Earnings Estimates
Las acciones de CytomX Therapeutics alcanzan un máximo de 52 semanas a 6,16 dólares
CytomX Therapeutics stock hits 52-week high at 6.16 USD
Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?
Piper Sandler raises CytomX Therapeutics stock price target to $10 on cancer drug data
CytomX Stock Rises 31% in a Month: Here's What You Should Know